Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

783 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Results of APL 91 European trial combining ATRA and chemotherapy: presentation of APL 1993 trial.
Fenaux P. Fenaux P. Leukemia. 1994;8 Suppl 3:S70-2. Leukemia. 1994. PMID: 7808029 Clinical Trial.
Arsenic trioxide-based therapy of relapsed acute promyelocytic leukemia: registry results from the European LeukemiaNet.
Lengfelder E, Lo-Coco F, Ades L, Montesinos P, Grimwade D, Kishore B, Ramadan SM, Pagoni M, Breccia M, Huerta AJ, Nloga AM, González-Sanmiguel JD, Schmidt A, Lambert JF, Lehmann S, Di Bona E, Cassinat B, Hofmann WK, Görlich D, Sauerland MC, Fenaux P, Sanz M; European LeukemiaNet. Lengfelder E, et al. Among authors: fenaux p. Leukemia. 2015 May;29(5):1084-91. doi: 10.1038/leu.2015.12. Epub 2015 Jan 28. Leukemia. 2015. PMID: 25627637
Azacitidine frontline therapy for unfit acute myeloid leukemia patients: clinical use and outcome prediction.
Ramos F, Thépot S, Pleyer L, Maurillo L, Itzykson R, Bargay J, Stauder R, Venditti A, Seegers V, Martínez-Robles V, Burgstaller S, Récher C, Debén G, Gaidano G, Gardin C, Musto P, Greil R, Sánchez-Guijo F, Fenaux P; European ALMA Investigators. Ramos F, et al. Among authors: fenaux p. Leuk Res. 2015 Mar;39(3):296-306. doi: 10.1016/j.leukres.2014.12.013. Epub 2014 Dec 31. Leuk Res. 2015. PMID: 25601157
All-trans retinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
Fenaux P, Chomienne C, Degos L. Fenaux P, et al. Semin Hematol. 2001 Jan;38(1):13-25. doi: 10.1016/s0037-1963(01)90002-2. Semin Hematol. 2001. PMID: 11172536 Review.
Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial.
de Botton S, Chevret S, Coiteux V, Dombret H, Sanz M, San Miguel J, Caillot D, Vekhoff A, Gardembas M, Stamatoulas A, Conde E, Guerci A, Gardin C, Fey M, Cony Makhoul D, Reman O, de la Serna J, Lefrere F, Chomienne C, Degos L, Fenaux P; European APL group. de Botton S, et al. Among authors: fenaux p. Leukemia. 2003 Feb;17(2):339-42. doi: 10.1038/sj.leu.2402807. Leukemia. 2003. PMID: 12592333 Clinical Trial.
A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.
Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L. Fenaux P, et al. Blood. 1999 Aug 15;94(4):1192-200. Blood. 1999. PMID: 10438706 Clinical Trial.
Tretinoin with chemotherapy in newly diagnosed acute promyelocytic leukaemia. European APL Group.
Fenaux P, Chastang C, Chomienne C, Degos L. Fenaux P, et al. Lancet. 1994 Apr 23;343(8904):1033. doi: 10.1016/s0140-6736(94)90151-1. Lancet. 1994. PMID: 7909058 Clinical Trial. No abstract available.
All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.
Degos L, Dombret H, Chomienne C, Daniel MT, Micléa JM, Chastang C, Castaigne S, Fenaux P. Degos L, et al. Among authors: fenaux p. Blood. 1995 May 15;85(10):2643-53. Blood. 1995. PMID: 7742522 Review. No abstract available.
Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.
Zwierzina H, Suciu S, Loeffler-Ragg J, Neuwirtova R, Fenaux P, Beksac M, Harousseau J, Nuessler V, Cermak J, Solbu G, Willemze R, de Witte T, Amadori S; EORTC Leukemia Cooperative Group. Zwierzina H, et al. Among authors: fenaux p. Leukemia. 2005 Nov;19(11):1929-33. doi: 10.1038/sj.leu.2403934. Leukemia. 2005. PMID: 16151466 Clinical Trial.
A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patients.
Bouabdallah R, Lefrère F, Rose C, Chaïbi P, Harousseau JL, Vernant JP, Castaigne S, Bauduer F, Zini JM, Coso D, Varet B, Robert J, Fenaux P. Bouabdallah R, et al. Among authors: fenaux p. Leukemia. 1999 Oct;13(10):1491-6. doi: 10.1038/sj.leu.2401522. Leukemia. 1999. PMID: 10516747 Clinical Trial.
783 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback